Aquestive Therapeutics, Inc. (AQST)
4.82
+0.12
(+2.55%)
USD |
NASDAQ |
Sep 24, 16:00
4.825
0.00 (0.00%)
Pre-Market: 19:59
Aquestive Therapeutics Gross Profit (Annual) : 27.39M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 27.39M |
| December 31, 2024 | 39.69M |
| December 31, 2023 | 29.97M |
| December 31, 2022 | 27.80M |
| December 31, 2021 | 35.84M |
| Date | Value |
|---|---|
| December 31, 2020 | 32.88M |
| December 31, 2019 | 32.25M |
| December 31, 2018 | 46.44M |
| December 31, 2017 | 47.10M |
| December 31, 2016 | 31.52M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| LENZ Therapeutics, Inc. | 18.38M |
| ANI Pharmaceuticals, Inc. | 450.64M |
| Corcept Therapeutics, Inc. | 748.43M |
| Veru, Inc. | -0.1521M |
| Johnson & Johnson | 64.63B |